{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:37:31Z","timestamp":1761766651495,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Okayama Health Foundation"},{"name":"Novartis Pharma Research Grants"},{"name":"Research for Promotion of Cancer Control Programs"},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We performed a follow up study about willingness and behaviors to quit smoking among smokers with schizophrenia in Japan.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Participants were outpatients with schizophrenia aged 20\u201369\u2009years who had been visiting the hospital for \u22651\u2009year as of April 1, 2016, and had visited the hospital more than once in the previous 6\u2009months. A baseline survey on smoking behaviors including current smoking status and smoking cessation stage, was administered in 420 participants that were randomly extracted from a patient pool (<jats:italic>n<\/jats:italic>\u2009=\u2009680) in 2016, and a follow-up survey was administered in 2017. We calculated the distribution and change in smoking cessation stage, number of smokers and nonsmokers after 1\u2009year, and quitting rate from a naturalistic 1-year smoking-cessation follow up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The number of baseline respondents was 350; 113 current smokers and 68 former smokers. Among the 113 current smokers, 104 (92.0%) were followed for 1\u2009year, 79 (70.0%) were interested in smoking cessation, and only 7 had received smoking cessation treatments at baseline. Among the tracked 104 participants, only 6 (5.8%) stopped smoking after 1\u2009year. Among the 25 participants who had intentions to quit smoking within 6\u2009months at baseline, 6 (24.0%) maintained their intention to quit smoking for 1\u2009year, and 16 (64.0%) did not maintain their intention to quit smoking.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings showed that many smokers with schizophrenia were interested in quitting smoking, but few patients received treatment and actually quit smoking. Timely intervention, including the option to receive smoking cessation treatment, is necessary for those patients with schizophrenia who smoke.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>UMIN Clinical Trials Registry (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/upload.umin.ac.jp\/cgi-open-bin\/ctr\/ctr_view.cgi?recptno=R000027437\">UMIN000023874<\/jats:ext-link>, registered on August 31, 2016).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-019-2351-9","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T16:03:17Z","timestamp":1574352197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Change in smoking cessation stage over 1\u2009year in patients with schizophrenia: a follow up study in Japan"],"prefix":"10.1186","volume":"19","author":[{"given":"Yuji","family":"Higuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Nakaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinatsu","family":"Hayashibara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuhei","family":"So","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuta","family":"Shinkawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Yada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Kakeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Uchitomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihito","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9822-8649","authenticated-orcid":false,"given":"Masatoshi","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"issue":"9","key":"2351_CR1","doi-asserted-by":"publisher","first-page":"812","DOI":"10.4088\/JCP.v63n0911","volume":"63","author":"J de Leon","year":"2002","unstructured":"de Leon J, Becona E, Gurpegui M, Gonzalez-Pinto A, Diaz FJ. The association between high nicotine dependence and severe mental illness may be consistent across countries. J Clin Psychiatry. 2002;63(9):812\u20136.","journal-title":"J Clin Psychiatry"},{"key":"2351_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.psychres.2018.12.064","volume":"272","author":"YY Wang","year":"2019","unstructured":"Wang YY, Wang S, Zheng W, Zhong BL, Ng CH, Ungvari GS, Wang CX, Xiang YT, Li XH. Cognitive functions in smoking and non-smoking patients with schizophrenia: a systematic review and meta-analysis of comparative studies. Psychiatry Res. 2019;272:155\u201363.","journal-title":"Psychiatry Res"},{"issue":"5","key":"2351_CR3","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/YCO.0000000000000529","volume":"32","author":"M Sagud","year":"2019","unstructured":"Sagud M, Mihaljevic Peles A, Pivac N. Smoking in schizophrenia: recent findings about an old problem. Curr Opin Psychiatry. 2019;32(5):402\u20138.","journal-title":"Curr Opin Psychiatry"},{"issue":"2\u20133","key":"2351_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.schres.2005.02.010","volume":"76","author":"J de Leon","year":"2005","unstructured":"de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res. 2005;76(2\u20133):135\u201357.","journal-title":"Schizophr Res"},{"issue":"1","key":"2351_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/ijnp\/pyy061","volume":"22","author":"K Ohi","year":"2019","unstructured":"Ohi K, Shimada T, Kuwata A, Kataoka Y, Okubo H, Kimura K, Yasuyama T, Uehara T, Kawasaki Y. Smoking rates and number of cigarettes smoked per day in schizophrenia: a large cohort meta-analysis in a Japanese population. Int J Neuropsychopharmacol. 2019;22(1):19\u201327.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"2351_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1176\/appi.ajp.2012.12050599","volume":"170","author":"C Crump","year":"2013","unstructured":"Crump C, Winkleby MA, Sundquist K, Sundquist J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry. 2013;170(3):324\u201333.","journal-title":"Am J Psychiatry"},{"issue":"9","key":"2351_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138147","volume":"10","author":"A Sankaranarayanan","year":"2015","unstructured":"Sankaranarayanan A, Mancuso S, Wilding H, Ghuloum S, Castle D. Smoking, Suicidality and psychosis: a systematic meta-analysis. PLoS One. 2015;10(9):e0138147.","journal-title":"PLoS One"},{"issue":"10","key":"2351_CR8","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S2213-2600(16)30228-4","volume":"4","author":"R Sharma","year":"2016","unstructured":"Sharma R, Gartner CE, Hall WD. The challenge of reducing smoking in people with serious mental illness. Lancet Respir Med. 2016;4(10):835\u201344.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"2351_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1001\/jama.2013.284985","volume":"311","author":"BL Cook","year":"2014","unstructured":"Cook BL, Wayne GF, Kafali EN, Liu Z, Shu C, Flores M. Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. JAMA. 2014;311(2):172\u201382.","journal-title":"JAMA."},{"issue":"10082","key":"2351_CR10","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/S0140-6736(17)30819-X","volume":"389","author":"GBD 2015 Tobacco Collaborators","year":"2017","unstructured":"GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990\u20132015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885\u2013906.","journal-title":"Lancet"},{"key":"2351_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev-publhealth-031816-044618","volume":"38","author":"JJ Prochaska","year":"2017","unstructured":"Prochaska JJ, Das S, Young-Wolff KC. Smoking, mental illness, and public health. Annu Rev Public Health. 2017;38:165\u201385.","journal-title":"Annu Rev Public Health"},{"key":"2351_CR12","doi-asserted-by":"publisher","first-page":"h4065","DOI":"10.1136\/bmj.h4065","volume":"351","author":"JW Tidey","year":"2015","unstructured":"Tidey JW, Miller ME. Smoking cessation and reduction in people with chronic mental illness. BMJ. 2015;351:h4065.","journal-title":"BMJ."},{"issue":"3","key":"2351_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1056\/NEJMp1105248","volume":"365","author":"JJ Prochaska","year":"2011","unstructured":"Prochaska JJ. Smoking and mental illness--breaking the link. N Engl J Med. 2011;365(3):196\u20138.","journal-title":"N Engl J Med"},{"issue":"2","key":"2351_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/wps.20332","volume":"15","author":"SA Schroeder","year":"2016","unstructured":"Schroeder SA. Smoking cessation should be an integral part of serious mental illness treatment. World Psychiatry. 2016;15(2):175\u20136.","journal-title":"World Psychiatry"},{"issue":"1","key":"2351_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/tc.2004.009886","volume":"15","author":"B Poland","year":"2006","unstructured":"Poland B, Frohlich K, Haines RJ, Mykhalovskiy E, Rock M, Sparks R. The social context of smoking: the next frontier in tobacco control? Tob Control. 2006;15(1):59\u201363.","journal-title":"Tob Control"},{"key":"2351_CR16","unstructured":"American Cancer Society. The Tobacco Atlas. 2019. https:\/\/tobaccoatlas.org\/. Accessed 30 Jan 2019."},{"key":"2351_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jad.2018.07.008","volume":"239","author":"M Fujiwara","year":"2018","unstructured":"Fujiwara M, Inagaki M, Nakaya N, Fujimori M, Higuchi Y, Kakeda K, Uchitomi Y, Yamada N. Smoking among adults with serious psychological distress: analysis of anonymized data from a national cross-sectional survey in Japan. J Affect Disord. 2018;239:131\u20137.","journal-title":"J Affect Disord"},{"key":"2351_CR18","volume-title":"The state of private confinement and its statistical observation of the mentally ill: modern translation. (in Japanese)","author":"S Kure","year":"2012","unstructured":"Kure S, Kashida G. The state of private confinement and its statistical observation of the mentally ill: modern translation. (in Japanese). Tokyo: Igakushoin; 2012."},{"key":"2351_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12991-015-0076-9","volume":"14","author":"K Hashimoto","year":"2015","unstructured":"Hashimoto K, Makinodan M, Matsuda Y, Morimoto T, Ueda S, Kishimoto T. Smoking bans in mental health hospitals in Japan: barriers to implementation. Ann General Psychiatry. 2015;14:35.","journal-title":"Ann General Psychiatry"},{"issue":"12","key":"2351_CR20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/pcn.12554","volume":"71","author":"M Fujiwara","year":"2017","unstructured":"Fujiwara M, Inagaki M, Nakaya N, Fujimori M, Higuchi Y, Hayashibara C, So R, Kakeda K, Kodama M, Uchitomi Y, et al. Cancer screening participation in schizophrenic outpatients and the influence of their functional disability on the screening rate: a cross-sectional study in Japan. Psychiatry Clin Neurosci. 2017;71(12):813\u201325.","journal-title":"Psychiatry Clin Neurosci"},{"key":"2351_CR21","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders, 5th edition","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition. Washington, DC: American Psychiatric Association; 2013."},{"key":"2351_CR22","unstructured":"World Health Organization. Guidelines for Controlling and Monitoring the Tobacco Epidemic: World Health Organization; 1998."},{"issue":"4","key":"2351_CR23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/BF02898094","volume":"9","author":"M Nakamura","year":"2004","unstructured":"Nakamura M, Masui S, Oshima A, Okayama A, Ueshima H, Group HR. Effects of stage-matched repeated individual counseling on smoking cessation: a randomized controlled trial for the high-risk strategy by lifestyle modification (HISLIM) study. Environ Health Prevent Med. 2004;9(4):152\u201360.","journal-title":"Environ Health Prevent Med"},{"issue":"3","key":"2351_CR24","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1037\/0022-006X.51.3.390","volume":"51","author":"JO Prochaska","year":"1983","unstructured":"Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51(3):390\u20135.","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"2351_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4278\/0890-1171-12.1.11","volume":"12","author":"JO Prochaska","year":"1997","unstructured":"Prochaska JO, Velicer WF. Misinterpretations and misapplications of the transtheoretical model. Am J Health Promot. 1997;12(1):11\u20132.","journal-title":"Am J Health Promot"},{"issue":"3","key":"2351_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0306-4603(97)00070-1","volume":"23","author":"A Dijkstra","year":"1998","unstructured":"Dijkstra A, Roijackers J, De Vries H. Smokers in four stages of readiness to change. Addict Behav. 1998;23(3):339\u201350.","journal-title":"Addict Behav"},{"issue":"1","key":"2351_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.amepre.2004.09.007","volume":"28","author":"VE Cokkinides","year":"2005","unstructured":"Cokkinides VE, Ward E, Jemal A, Thun MJ. Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med. 2005;28(1):119\u201322.","journal-title":"Am J Prev Med"},{"issue":"7","key":"2351_CR28","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1989.tb03059.x","volume":"84","author":"TF Heatherton","year":"1989","unstructured":"Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989;84(7):791\u20139.","journal-title":"Br J Addict"},{"issue":"2","key":"2351_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1046\/j.1360-0443.1999.94226910.x","volume":"94","author":"JF Etter","year":"1999","unstructured":"Etter JF, Duc TV, Perneger TV. Validity of the Fagerstrom test for nicotine dependence and of the heaviness of smoking index among relatively light smokers. Addiction. 1999;94(2):269\u201381.","journal-title":"Addiction."},{"key":"2351_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1186\/1471-2458-9-493","volume":"9","author":"M Perez-Rios","year":"2009","unstructured":"Perez-Rios M, Santiago-Perez MI, Alonso B, Malvar A, Hervada X, de Leon J. Fagerstrom test for nicotine dependence vs heavy smoking index in a general population survey. BMC Public Health. 2009;9:493.","journal-title":"BMC Public Health"},{"key":"2351_CR31","unstructured":"Statistics Bureau Ministry of Internal Affairs and Communications. Portal site of official statistics of Japan. 2017. Available from: https:\/\/www.e-stat.go.jp\/en. Accessed 30 Jan 2019."},{"issue":"4","key":"2351_CR32","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3109\/00048670903489841","volume":"44","author":"A Baker","year":"2010","unstructured":"Baker A, Richmond R, Lewin TJ, Kay-Lambkin F. Cigarette smoking and psychosis: naturalistic follow up 4 years after an intervention trial. Aust N Z J Psychiatry. 2010;44(4):342\u201350.","journal-title":"Aust N Z J Psychiatry"},{"issue":"6","key":"2351_CR33","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s40263-017-0438-8","volume":"31","author":"C Cather","year":"2017","unstructured":"Cather C, Pachas GN, Cieslak KM, Evins AE. Achieving smoking cessation in individuals with schizophrenia: special considerations. CNS Drugs. 2017;31(6):471\u201381.","journal-title":"CNS Drugs"},{"issue":"4","key":"2351_CR34","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1037\/0033-2909.133.4.673","volume":"133","author":"SM Noar","year":"2007","unstructured":"Noar SM, Benac CN, Harris MS. Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions. Psychol Bull. 2007;133(4):673\u201393.","journal-title":"Psychol Bull"},{"issue":"7400","key":"2351_CR35","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1136\/bmj.326.7400.1175","volume":"326","author":"RP Riemsma","year":"2003","unstructured":"Riemsma RP, Pattenden J, Bridle C, Sowden AJ, Mather L, Watt IS, Walker A. Systematic review of the effectiveness of stage based interventions to promote smoking cessation. BMJ. 2003;326(7400):1175\u20137.","journal-title":"BMJ."},{"issue":"5","key":"2351_CR36","first-page":"475","volume":"64","author":"M Nakamura","year":"2015","unstructured":"Nakamura M. Article 14 of the World Health Organization framework convention on tobacco control: demanding reduction measures concerning tobacco dependence and cessation. (in Japanese). Hoken Iryo Kagaku. 2015;64(5):475\u201383.","journal-title":"Hoken Iryo Kagaku"},{"key":"2351_CR37","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fpsyt.2018.00428","volume":"9","author":"S Ahmed","year":"2018","unstructured":"Ahmed S, Virani S, Kotapati VP, Bachu R, Adnan M, Khan AM, Zubair A, Begum G, Kumar J, Qureshi M, et al. Efficacy and safety of Varenicline for smoking cessation in schizophrenia: a meta-analysis. Front Psychiatry. 2018;9:428.","journal-title":"Front Psychiatry"},{"issue":"6","key":"2351_CR38","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1001\/jama.2018.21557","volume":"321","author":"SJ Leischow","year":"2019","unstructured":"Leischow SJ. Increasing smoking cessation in the United States: expanding the availability of over-the-counter medications. JAMA. 2019;321(6):541\u20132.","journal-title":"JAMA."},{"key":"2351_CR39","volume":"2","author":"DT Tsoi","year":"2013","unstructured":"Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev. 2013;2:CD007253.","journal-title":"Cochrane Database Syst Rev"},{"key":"2351_CR40","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.drugalcdep.2017.05.046","volume":"178","author":"PH Smith","year":"2017","unstructured":"Smith PH, Zhang J, Weinberger AH, Mazure CM, McKee SA. Gender differences in the real-world effectiveness of smoking cessation medications: findings from the 2010-2011 tobacco use supplement to the current population survey. Drug Alcohol Depend. 2017;178:485\u201391.","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"2351_CR41","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1185\/03007995.2014.938149","volume":"30","author":"A Igarashi","year":"2014","unstructured":"Igarashi A, Negishi S, Goto R, Suwa K. Web-based survey on smoking cessation behaviors of current and former smokers in Japan. Curr Med Res Opin. 2014;30(10):1911\u201321.","journal-title":"Curr Med Res Opin"},{"key":"2351_CR42","unstructured":"Central Social Insurance Medical Council. Research report on the effects of smoking cessation treatment covered by health insurance (in Japanese). 2017. https:\/\/www.mhlw.go.jp\/file\/05-Shingikai-12404000-Hokenkyoku-Iryouka\/0000192293.pdf. Accessed 9 Aug 2019."},{"issue":"3","key":"2351_CR43","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1440-1819.2010.02082.x","volume":"64","author":"T Takeuchi","year":"2010","unstructured":"Takeuchi T, Nakao M, Shinozaki Y, Yano E. Validity of self-reported smoking in schizophrenia patients. Psychiatry Clin Neurosci. 2010;64(3):274\u20138.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"4","key":"2351_CR44","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3109\/13651501.2010.505342","volume":"14","author":"T Takeuchi","year":"2010","unstructured":"Takeuchi T, Nakao M, Shinozaki Y, Yano E. Validity of the self-reported smoking status of schizophrenia patients, taking gender-related differences into consideration. Int J Psychiatry Clin Pract. 2010;14(4):282\u20136.","journal-title":"Int J Psychiatry Clin Pract"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-019-2351-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-019-2351-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-019-2351-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T02:18:28Z","timestamp":1605838708000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-019-2351-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2351"],"URL":"https:\/\/doi.org\/10.1186\/s12888-019-2351-9","relation":{},"ISSN":["1471-244X"],"issn-type":[{"type":"electronic","value":"1471-244X"}],"subject":[],"published":{"date-parts":[[2019,11,21]]},"assertion":[{"value":"13 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was given by the institutional ethics committee of the Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences and the institutional review board of Okayama University Hospital (approval number KEN1608\u2013010), and by the Okayama Psychiatric Medical Center (approval number 27\u201338). All participants provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"YH has nothing to disclose related to this paper. MF1 reports grants from: Okayama Health Foundation, Novartis Pharma, Research for Promotion of Cancer Control Programs, and Eisai Co., Ltd. during this study; and personal fees from: Mochida Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Sumitomo Dainippon Pharma Co., Ltd., Sentan Igaku-sha Ltd., Igaku-Shoin Ltd., Iyaku (Medicine and Drug) Journal Co., Ltd. outside the submitted work. RS reports personal fees from Kagakuhyronsha Co., Ltd., Medical Review Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Igaku Shoin Co., Ltd. outside the submitted work. KK reports personal fees from Mochida Pharmaceutical Co., Ltd. outside the submitted work. NY reports grants from Okayama Health Foundation, Novartis Pharma, Research for Promotion of Cancer Control Programs, and Eisai Co., Ltd. during this study; grants from the Japanese Ministry of Education, Science, and Technology; grants and personal fees from Daiichi Sankyo Co., Ltd., Eisai Co., Ltd., and Otsuka Pharmaceutical Co., Ltd.; grants from Astellas Pharma Inc., and grants and personal fees from MSD KK and Pfizer Inc.; personal fees from Meiji Seika Pharma Co., Ltd., Janssen Pharmaceutical KK, Hisamitsu Pharmaceutical Co., Inc., Sumitomo Dainippon Pharma Co., Ltd., Mochida Pharmaceutical Co., Ltd., and Tsumura & Co.; and grants and personal fees from Takeda Pharmaceutical Co., Ltd. outside the submitted work. MI reports grants from Okayama Health Foundation, Novartis Pharma, Research for Promotion of Cancer Control Programs during this study; grants and personal fees from Takeda Pharmaceutical Co., Ltd., Pfizer Inc., Eisai Co., Ltd., and MSD KK; grants from Astellas Pharma Inc. and Daiichi Sankyo Co., Ltd.; personal fees from Meiji Seika Pharma Co., Ltd., Mochida Pharmaceutical Co., Ltd., Novartis Pharma, Otsuka Pharmaceutical Co., Ltd., Yoshitomiyakuhin Corporation, and Technomics, Inc., outside the submitted work. The other authors have nothing to disclose related to this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"367"}}